Tempus AI stock surged to a record high Monday, and then dipped, after the FDA cleared its new device to help drugmakers ...

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric neurology through three poster presentations and a ...

Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510 (k) clearance from the U.S. Food and ...

Alcohol doesn’t just damage the liver — it locks its cells in a strange “in-between” state that prevents them from healing.

Autism-linked genes evolved rapidly in humans. They may have aided brain growth and language. A recent study published in Molecular Biology and Evolution by Oxford University Press suggests that the r ...

Let us know. Catch every headline in your inbox ...

Background Molecular genetic diagnoses are critical to prevention and treatment of inherited polyposis and colorectal cancer.

Researchers at the Max Planck Institute for Brain Research have mapped the molecular landscape of the mouse hippocampus, a ...

A real-world study showed that patients who had the classical subtype based on an RNA signature had better survival on ...